GlaxoSmithKline is cutting the price charged for its pneumococcal vaccine when given to refugees, following complaints about the product's “exorbitant” cost by medical charity Medecins Sans Frontieres. GSK said its offer was made on the basis that others would not seek to reference the special price, which is intended solely to support refugee populations. Pfizer also makes a pneumococcal vaccine called Prevnar.
Original post:
GSK cuts vaccine price for refugees, bowing to pressure
